Clinical Trial Update: Trial in Low Grade Glioma Patients: Wait or Treat [Phase 3]

View source ↗

Summary

A Phase 3 trial in low-grade glioma evaluating a wait-and-treat strategy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Low-grade Glioma, Temozolomide | Phase 3 | Status: TERMINATED